Schizophrenia Research
Volume 134, Issue 1 , Pages 10-15 , January 2012

Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence

  • Tim B. Ziermans

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author at: Department of Neuroscience, Retzius Väg 8, Karolinska Institutet, 171 77 Stockholm, Sweden. Tel.: +46 8 524 86 372.
    • ,
  • Patricia F. Schothorst

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Mirjam Sprong

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Maurice J.C.M. Magnée

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Herman van Engeland

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Chantal Kemner

      Affiliations

    • Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    • Department of Developmental Psychology, Faculty of Social Sciences, Utrecht University, The Netherlands

Received 18 January 2010 ,Revised 4 October 2011 ,Accepted 20 October 2011.

References 

  1. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001;156(2–3):234–258
  2. Bramon E, Shaikh M, Broome M, Lappin J, Berge D, Day F, et al. Abnormal P300 in people with high risk of developing psychosis. Neuroimage. 2008;41(2):553–560
  3. Brockhaus-Dumke A, Tendolkar I, Pukrop R, Schultze-Lutter F, Klosterkotter J, Ruhrmann S. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr. Res. 2005;73(2–3):297–310
  4. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, et al. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol. Psychiatry. 2008;64(5):376–384
  5. Cadenhead KS. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res. 2011;188(2):208–216
  6. Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol. Psychiatry. 2005;57(12):1504–1509
  7. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry. 2008;65(1):28–37
  8. Frommann I, Brinkmeyer J, Ruhrmann S, Hack E, Brockhaus-Dumke A, Bechdolf A, et al. Auditory P300 in individuals clinically at risk for psychosis. Int. J. Psychophysiol. 2008;70(3):192–205
  9. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch. Gen. Psychiatry. 2007;64(11):1242–1250
  10. Halberstadt AL, Geyer MA. Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors. Neurobiol. Learn. Mem. 2009;92(2):243–248
  11. Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl). 2002;162(2):97–101
  12. Magnee MJ, Oranje B, van Engeland H, Kahn RS, Kemner C. Cross-sensory gating in schizophrenia and autism spectrum disorder: EEG evidence for impaired brain connectivity?. Neuropsychologia. 2009;47(7):1728–1732
  13. McGlashan TH, Miller TJ, Woods SW. Structured Interview for Prodromal Syndromes (SIPS) — version 3.0. New Haven: PRIME Research Clinic, Yale School of Medicine; 2001;
  14. Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol. Psychiatry. 2004;55(7):663–667
  15. Nieman D, Becker H, van de Fliert R, Plat N, Bour L, Koelman H, et al. Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophr. Res. 2007;95(1–3):54–60
  16. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr. Scand. 2006;113(4):247–272
  17. Oranje B, Jensen K, Wienberg M, Glenthoj BY. Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention. Int. J. Neuropsychopharmacol. 2008;11(4):453–463
  18. Ozgurdal S, Gudlowski Y, Witthaus H, Kawohl W, Uhl I, Hauser M, et al. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr. Res. 2008;105(1–3):272–278
  19. Quednow BB, Frommann I, Berning J, Kuhn KU, Maier W, Wagner M. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol. Psychiatry. 2008;64(9):766–773
  20. Ross RG, Heinlein S, Zerbe GO, Radant A. Saccadic eye movement task identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives. J. Child Psychol. Psychiatry. 2005;46(12):1354–1362
  21. Schultze-Lutter F, Klosterkötter J. Bonn Scale for the Assessment of Basic Symptoms-Prediction list (BSABS-P). Cologne: University of Cologne; 2002;
  22. Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, et al. Neurodevelopmental trajectories of the human cerebral cortex. J. Neurosci. 2008;28(14):3586–3594
  23. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. Neuroimaging predictors of transition to psychosis — a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2010;34(8):1207–1222
  24. Sprong M, Becker HE, Schothorst PF, Swaab H, Ziermans TB, Dingemans PM, et al. Pathways to psychosis: a comparison of the pervasive developmental disorder subtype Multiple Complex Developmental Disorder and the “At Risk Mental State”. Schizophr. Res. 2008;99(1–3):38–47
  25. Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 2001;156(2–3):194–215
  26. Thaker GK. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr. Bull. 2008;34(4):760–773
  27. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007;33(1):69–94
  28. van Rijn S, Swaab H, Magnee M, van Engeland H, Kemner C. Psychophysiological markers of vulnerability to psychopathology in men with an extra X chromosome (XXY). PLoS One. 2011;6(5):e20292
  29. van Tricht MJ, Nieman DH, Bour LJ, Boeree T, Koelman JH, de Haan L, et al. Increased saccadic rate during smooth pursuit eye movements in patients at Ultra High Risk for developing a psychosis. Brain Cogn. 2010;73(3):215–221
  30. van Tricht MJ, Nieman DH, Koelman JH, van der Meer JN, Bour LJ, de Haan L, et al. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol. Psychiatry. 2010;68(7):642–648
  31. van Tricht MJ, Nieman DH, Koelman JH, Bour LJ, van der Meer JN, van Amelsvoort TA, et al. Auditory ERP components before and after transition to a first psychotic episode. Biol. Psychol. 2011;87(3):350–357
  32. Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology. 2009;34(3):739–746
  33. Wechsler D. Wechsler Adult Intelligence Scale-III NL: Afname en scoringshandleiding. The Psychological Corporation Ltd, Harcourt Publishers; 1997;
  34. Wechsler D. Wechsler Intelligence Scale for Children-III NL: Handleiding en verantwoording. The Psychological Corporation Ltd, Harcourt Assessment; 2002;
  35. Wetzel N, Widmann A, Berti S, Schroger E. The development of involuntary and voluntary attention from childhood to adulthood: a combined behavioral and event-related potential study. Clin. Neurophysiol. 2006;117(10):2191–2203
  36. Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr. Bull. 2003;29(4):831–843
  37. Yee CM, Williams TJ, White PM, Nuechterlein KH, Ames D, Subotnik KL. Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia. J. Abnorm. Psychol. 2010;119(1):31–39
  38. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr. Res. 2008;105(1–3):10–17
  39. Ziermans TB, Durston S, Sprong M, Nederveen H, van Haren NE, Schnack HG, et al. No evidence for structural brain changes in young adolescents at ultra high risk for psychosis. Schizophr. Res. 2009;112(1–3):1–6
  40. Ziermans T, Schothorst P, Magnee M, van Engeland H, Kemner C. Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study. J. Psychiatry Neurosci. 2011;36(2):127–134
  41. Ziermans TB, Schothorst PF, Sprong M, van Engeland H. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr. Res. 2011;126(1–3):58–64

PII: S0920-9964(11)00544-5

doi: 10.1016/j.schres.2011.10.009

Schizophrenia Research
Volume 134, Issue 1 , Pages 10-15 , January 2012

Article Tools

* Image Usage & Resolution